Navigation Links
Cynosure's Cellulaze Cellulite Laser Work Station Receives Korean Regulatory Approval
Date:11/30/2011

WESTFORD, Mass., Nov. 30, 2011 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that it has received market approval from the Korea Food & Drug Administration (KFDA) for its Cellulaze™ Cellulite Laser Workstation.  Sales through Cynosure Korea, the Company's wholly owned subsidiary in Seoul, Korea, are expected to begin in the first quarter of 2012.

Cellulaze is the world's first minimally invasive aesthetic device designed for the long-term reduction of cellulite. The product received CE Mark certification in February 2011, and is currently being marketed in the European Union.  Cellulaze also is cleared for marketing in Australia and Canada. Cynosure's 510(k) application for marketing clearance of Cellulaze in the United States is being reviewed by the U.S. Food and Drug Administration.

"Success in international markets remains key to our long-term growth strategy," said Michael Davin, Cynosure's president and chief executive officer.  "The KFDA's approval of Cellulaze reflects both the increasing global adoption of this highly effective solution for long-term cellulite reduction, and our ongoing progress in bringing Cynosure's innovative technology to consumers worldwide."

Approximately 85% of women over the age of 20(1,2) have some form of cellulite – pockets of fat deposited just beneath the surface of the skin, around the hips, thighs, and buttocks, which produces an "orange-peel" or a "cottage cheese" appearance(3). In the United States alone, treatment of cellulite is a multibillion-dollar industry, according to market estimates.

Cellulaze uses a proprietary SideLight 3D™ side-firing technology to target the exact causes of cellulite beneath the skin: herniated pockets of fat, stiffened septae and thin skin. During the procedure, a tiny laser fiber is inserted under the skin, which gently heats the skin and disrupts or melts the fat. Next the laser releases the fibrous bands that create the dimpling effect from pulling down on the skin. This release creates a smoother look.  Finally the laser's energy stimulates collagen production to increase skin's depth and elasticity for a more even, healthier appearance.Patients usually see improvements within a few weeks, with the most significant results continuing to develop for a few months following the procedure.  Cellulaze also complements other body shaping technologies, such as Cynosure's Smartlipo™ family of workstations. Together, these technologies synergistically deliver the benefits of cellulite reduction and skin tightening through tissue coagulation.  

About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce the appearance of cellulite and treat Onychomycosis. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.

Forward-Looking Statements
Any statements in this press release about future expectations, plans and prospects for Cynosure, Inc., as well as other statements containing the words "believes," "anticipates," "plans," "expects," "will" and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the global economy and lending environment and their effects on the aesthetic laser industry, Cynosure's history of operating losses, its reliance on sole source suppliers, the inability to accurately predict the timing or outcome of regulatory decisions, changes in consumer preferences, competition in the aesthetic laser industry, economic, market, technological and other factors discussed in Cynosure's most recent Annual Report on Form 10-K, which is filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, while Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.

 

(1) Harvard Women's Health Watch Cellulite meltdown. Harv. Health Pub. Group 5, 7 (1998).
(2) Sainio, E.L., Rantanen, T. and Kanerva, L. Ingredients and safety of cellulite creams. Eur. J. Dermatol. 10, 596–603 (2000).
(3) Drealos, Z.D. and Marenus, K.D. Cellulite: etiology and purported treatment. Dermatol. Surg. 23, 1177–1181 (1997).  Timothy Baker Scott SolomonExecutive VP, Treasurer and CFO

 

Vice President Cynosure, Inc.

 

Sharon Merrill 978.256.4200

 

617.542.5300TBaker@cynosure.com

 

CYNO@investorrelations.com 


'/>"/>
SOURCE Cynosure, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cynosure Introduces Cellulaze, the Worlds First Aesthetic Laser Device for the Long-Term Reduction of Cellulite
2. Cynosure Receives Additional International Regulatory Approvals for New Cellulite Reduction Workstations
3. Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products
4. American Laser Center Offers VelaShape Body Shaping and Cellulite Reduction Treatment
5. Ellman International Introduces the New Ellumine Laser at the American Society for Dermatologic Surgery (ASDS) 2011 Annual Meeting
6. IRIDEX Launches New MicroPulse™ Module Targeting the Broad Ophthalmology Laser Photocoagulation Market
7. Aesthetic Lasers and Energy Devices - Global Market Briefing to 2017
8. XTRAC Excimer Laser Provides Relief for Psoriasis Sufferers Fall Flare-Ups
9. In Honor of National Breast Cancer Awareness Month, Alma Lasers Launches Nationwide Radiation Tattoo Removal Program, Declare Your Freedom
10. Cynosure Acquires Worldwide Exclusive Rights to Distribute PinPointe™ FootLaser™ for Treatment of Onychomycosis
11. In Support of National Breast Cancer Awareness Month, Alma Lasers Launches Nationwide Radiation Tattoo Removal Program, Declare Your Freedom.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):